日本消化器病学会アーカイブシステム

セッション	検索結果は4件です。 Downstaging of locally advanced pancreatic adenocarcinoma with prolonged neoadjuvant therapy Reber　Howard A.（David Geffen School of Medicine at UCLA, USA） Rationale：The treatment of patients with locally advanced pancreatic ductal adenocarcinoma（PDAC）varies, with some advocating prompt surgery, usually with vascular resection and others employing... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment Multimodality therapy for borderline resectable pancreatic cancer：Is neoadjuvant chemoradiation necessary? Picozzi　Vincent J（Digestive Disease Institute, Virginia Mason Medical Center, USA） Background：The optimal surgical（S）approach to BRPC is unknown. We evaluated an approach to BPRC using extended course chemotherapy（CT）without routine neoadjuvant chemoradiation（CRT）. Clinical o... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment Distal Pancreatectomy with Celiac Axis Resection（DP-CAR）for borderline resectable panceras body cancer Yamaue　Hiroki（Second Department of Surgery, Wakayama Medical University, Japan）　The indications for distal pancreatectomy with en-bloc celiac axis resection（DP-CAR）were extended recently to increase the R0 rate for advanced pancreatic body/tail carcinoma. Moreover, it is well re... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment Preoperative chemoradiotherapy for borderline resectable pancreatic ductal adenocarcinoma Isaji　Shuji（Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Japan）　Background：Chemoradiotherapy prior to surgery（CRT-S）for pancreatic ductal adenocarcinoma（PDAC）may provide for early treatment of micrometastatic disease, allows for identification of the patients wit... 第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment

セッション

検索結果は4件です。

Downstaging of locally advanced pancreatic adenocarcinoma with prolonged neoadjuvant therapy: Reber　Howard A.（David Geffen School of Medicine at UCLA, USA）
Rationale：The treatment of patients with locally advanced pancreatic ductal adenocarcinoma（PDAC）varies, with some advocating prompt surgery, usually with vascular resection and others employing...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment
Multimodality therapy for borderline resectable pancreatic cancer：Is neoadjuvant chemoradiation necessary?: Picozzi　Vincent J（Digestive Disease Institute, Virginia Mason Medical Center, USA）
Background：The optimal surgical（S）approach to BRPC is unknown. We evaluated an approach to BPRC using extended course chemotherapy（CT）without routine neoadjuvant chemoradiation（CRT）. Clinical o...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment
Distal Pancreatectomy with Celiac Axis Resection（DP-CAR）for borderline resectable panceras body cancer: Yamaue　Hiroki（Second Department of Surgery, Wakayama Medical University, Japan）
　The indications for distal pancreatectomy with en-bloc celiac axis resection（DP-CAR）were extended recently to increase the R0 rate for advanced pancreatic body/tail carcinoma. Moreover, it is well re...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment
Preoperative chemoradiotherapy for borderline resectable pancreatic ductal adenocarcinoma: Isaji　Shuji（Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Japan）
　Background：Chemoradiotherapy prior to surgery（CRT-S）for pancreatic ductal adenocarcinoma（PDAC）may provide for early treatment of micrometastatic disease, allows for identification of the patients wit...
第100回日本消化器病学会総会＞ II　Challenge to the pancreatic and biliary cancers　3. Pancreatic cancer―Challenge to the better treatment